-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Bionano Genomics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2017 to Q3 2024.
- Bionano Genomics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$321K, a 147% decline year-over-year.
- Bionano Genomics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$18.8M, a 869% decline year-over-year.
- Bionano Genomics, Inc. annual Nonoperating Income (Expense) for 2023 was -$17.2M, a 1843% decline from 2022.
- Bionano Genomics, Inc. annual Nonoperating Income (Expense) for 2022 was $986K.
- Bionano Genomics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.05M, a 58.4% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)